Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

595 results about "Differential expression" patented technology

Differential expression allows identifying features (genes, proteins, metabolites…) that are significantly affected by explanatory variables. For example, we might be interested in identifying proteins that are differentially expressed between healthy and diseased individuals.

Spatial omics multi-modal fusion method under single cell level

A spatial omics multi-modal fusion method under a single cell level comprises the following steps: extracting spatial morphological characteristics of differential expression genes and cell nucleuses from spatial transcriptome data, single cell sequencing data and histological images, and realizing field adaptation among different platforms by using a conditional variation auto-encoder. And based on a probability inference model, fusing spatial transcriptome expression, unicellular omics and morphological characteristics, and jointly inferring the type and gene expression level of each cell. A spatial cell network is constructed through a graph attention mechanism, and spatial diffusion and recognition of cell types in a full slice range are realized. In combination with a multi-omics enhancement module, undetected gene and protein expression is completed based on expression similarity, and prediction consistency is improved through spatial correction. According to the method, high-resolution reconstruction of single-cell multi-omics information in a three-dimensional space is realized, the information coverage and spatial resolution of spatial omics data are improved, and an efficient and low-cost solution is provided for spatial biology and precise medical research.
Owner:HARBIN INSTITUTE OF TECHNOLOGY (SHENZHEN) (INSTITUTE OF SCIENCE AND TECHNOLOGY INNOVATION HARBIN INSTITUTE OF TECHNOLOGY SHENZHEN)

Key node identification method of disease marker expression regulation and control network

The invention provides a key node identification method for a disease marker expression regulation network, and belongs to the technical field of disease markers, and the method comprises the steps: firstly carrying out the preprocessing and quality control of original data, including batch effect removal, abnormal sample identification and the like; then identifying differential expression genes through multiple difference analysis and a pre-training model, and constructing a gene expression correlation network; and integrating multi-source regulation and control data to construct a multi-level weighted network, calculating network node features, and carrying out representation learning and module division. And based on multi-dimensional features such as network topology features, module contribution degree and biological importance, a neural network model is trained to carry out key node identification. And finally, optimizing the model through multi-layer verification such as pathway enrichment, disease gene overlapping, expression stability, time sequence change and network disturbance, and finally obtaining a verified key node set. The problem that in the prior art, the interaction relation between molecules is ignored, and consequently some key regulation and control nodes are possibly missed is solved.
Owner:QINGDAO RAISECARE BIOTECHNOLOGY CO LTD

Autophagy biomarker related to depression, risk assessment model and application of autophagy biomarker

The invention discloses an autophagy biomarker related to depression, a risk assessment model and application of the autophagy biomarker. A group of autophagy related biomarkers for auxiliary diagnosis of depression are screened out through multi-dimensional screening of large sample data and a machine learning algorithm, the autophagy related biomarkers comprise the following genes: GABARAPL2, RB1CC1, FOS and ULK1, and differential expression of the autophagy related biomarkers is proved in chronic stress induced depression-like mouse cortical brain tissues. The invention also provides a risk assessment model for auxiliary diagnosis of depression, a logistic regression model is constructed by taking the biomarker as a feature, a score formula and a risk boundary value of depression risk assessment are determined, and multi-aspect assessment is carried out on the prediction performance of the model. The prediction model has good prediction accuracy and calibration degree, can efficiently and conveniently realize early diagnosis of depression, and improves the accuracy of depression treatment.
Owner:SOUTHEAST UNIV

Database visualization method based on single cell

The invention relates to the technical field of single cell data processing, in particular to a database visualization method based on single cells. The method comprises the following steps: acquiring a single cell data set; standardizing the single cell data set to obtain standardized single cell data; performing high-dimensional feature extraction on the standardized single-cell data to obtain single-cell high-dimensional feature data; and performing nonlinear dimension reduction processing on the single-cell high-dimensional feature data to obtain single-cell dimension reduction data. Performing data clustering on the single cell dimension reduction data to obtain single cell clustering data; performing gene differential expression extraction on the single cell clustering data to obtain differential expression gene data; multi-modal data fusion analysis is carried out on single cell data through a data processing technology, a feature mapping technology and a visualization technology; and dynamic weight division is carried out on the single cell database, so that the effect of visualization of the single cell database is enhanced.
Owner:ZEBRAFISH (BEIJING) TECHNOLOGY CO LTD

Drug relocation method and system

The invention provides a drug relocation method and a drug relocation system. The method comprises the following steps: predicting an expression profile of a drug after cell line disturbance according to a chemical structure of the drug, dose information of the drug and an undisturbed expression profile. And calculating the differential expression profile of the gene in the cell line based on the expression profiles before and after the cell line is disturbed by the drug. And for each drug, according to the differential expression profiles of the genes, calculating an average value of the differential expression profiles of the genes after the drugs disturb different cell lines, and sorting the genes based on the average value to obtain a sorting list of the differential expression profiles of the drugs. And according to the gene characteristics of the target disease and the sorting list, calculating the enrichment score of each drug on the target disease, and according to the enrichment score, evaluating the potential efficacy of the drug on the target disease. The drug relocation method provided by the invention can be used for giving disease specific gene characteristics for drug library screening.
Owner:INST OF COMPUTING TECH CHINESE ACAD OF SCI

Experimental method for relation between cytokine level and tumor immune microenvironment in circulation

The invention discloses an experimental method for relation between cytokine level and tumor immune microenvironment in circulation, which comprises the following steps of: S1, collecting colorectal cancer patient data and normal data for contrast, and preferably screening a gene expression data set from a Gene Expression Omnibus (GEO) database; according to the method, a plurality of gene expression data sets from the GEO database are collected and analyzed, so that differential expression genes between colorectal cancer and normal tissues can be systematically identified, and a solid foundation is provided for subsequent research. The process not only covers batch correction, normalization and batch effect elimination of data, but also visually presents data distribution changes through principal component analysis, ensures the accuracy and reliability of analysis results, confirms that IL6 and IFN gamma are one of the most critical factors affecting the colorectal cancer immune microenvironment, and participate in formation of immune infiltration.
Owner:CHONGQING MEDICAL UNIVERSITY

Application of detection reagent for hair follicle development related genes of down producing goat

The invention relates to the technical field of gene engineering, in particular to application of a detection reagent for a hair follicle development related gene of a down producing goat. According to the present invention, the Cashmere goat hair follicle development related gene is any one or more of lncRNA MSTRG.20890.1, chi-miR-24-3p and ADAMTS3, and the lncRNA MSTRG.20890.1 and the ADAMTS3 are competitively combined with the chi-miR-24-3p, such that the significant differential expression of the lncRNA MSTRG.20890.1 in the Cashmere goat secondary hair follicle morphogenesis process is found, and the results prove that the lncRNA MSTRG.20890.1 can regulate the proliferation and the migration of dermal fibroblasts through the competitive combination of the lncRNA MSTRG.20890.1 and the ADAMTS3, such that the growth of the Cashmere goat secondary hair follicle morphogenesis can be inhibited therefore, the formation of a dermal papilla structure is inhibited.
Owner:INNER MONGOLIA AGRICULTURAL UNIVERSITY

Differential thyroid cancer lung metastasis risk prediction model construction method and system

The invention discloses a differentiated thyroid cancer lung metastasis risk prediction model construction method and system. 4D Label-free quantitative proteomics analysis and PRM and IHC dual verification are carried out on primary focus paraffin embedded tissue samples of lung metastatic DTC patients and non-lung metastatic DTC patients, and it is found that multiple key differential expression proteins DEPs may become potential biomarkers for predicting the DTC lung metastasis risk. In addition, the sample size is enlarged, three single and combined DTC lung metastasis risk prediction models are respectively constructed based on clinical features and key DEPs expression, then internal verification is performed on the efficiency of the three fitted models, and the optimal model is taken to construct Nomogram. According to the method, help is provided for risk stratification of lung metastasis of DTC patients, and an important basis is provided for formulating clinical individualized treatment schemes and follow-up visit strategies for high-risk patients.
Owner:YUNNAN CANCER HOSPITAL (THE THIRD AFFILIATED HOSPITAL OF KUNMING MEDICAL UNIV)

Application of PABPC3 as marker for evaluating prognosis of metastatic ovarian cancer

The invention discloses application of PABPC3 as a marker for evaluating prognosis of metastatic ovarian cancer, and belongs to the technical field of biological diagnosis and medicine. Specifically, differential genes in an in-situ ovarian cancer and a metastatic ovarian cancer in a database are screened, and are combined with differential genes related to ovarian cancer prognosis in a pan-cancer database, so that a gene PABPC3 with remarkable differential expression is obtained. The influence of the gene PABPC3 on the activity, migration ability and the like of ovarian cancer cells is researched through cell experiments and in-vivo experiments, and the feasibility of the marker in evaluation of ovarian cancer prognosis is proved. Meanwhile, the invention also discovers that the expression of the knock-down gene PABPC3 can inhibit the metastasis of cancer cells. Therefore, the invention provides a novel strategy for detecting and treating ovarian cancer metastasis, which is expected to overcome the defects of the traditional detection and treatment mode, and provides a new choice for clinic.
Owner:SUZHOU UNIV

Method for constructing prognosis model related to neoadjuvant chemotherapy pyroptosis of breast cancer

The invention discloses a breast cancer neoadjuvant chemotherapy pyroptosis related prognosis model construction method which comprises the following steps: obtaining an original data set, and preprocessing to obtain an annotated whole-gene expression matrix and a survival clinical information matrix; screening out a gene database having significant differential expression on patient survival; obtaining a pyroptosis related gene database; taking an intersection of the pyroptosis related gene database and the gene database having significant differential expression on the survival of the patient to obtain a list of differential expression genes related to the survival of the pyroptosis; and carrying out disease survival prediction model batch construction on the differential expression gene list, screening out two optimal disease survival prediction models as sub-models, and weighting to obtain a prognosis model. According to the method, the problem that gene pathways of a prognosis model of the breast cancer neoadjuvant chemotherapy patient are deficient is solved, and the prognosis prediction capability of the breast cancer patient receiving the neoadjuvant chemotherapy is expected to be improved.
Owner:RENMIN HOSPITAL OF WUHAN UNIVERSITY (HUBEI GENERAL HOSPITAL)

Intelligent analysis method and system for heterogeneity of endothelial cells in atherosclerosis

The invention discloses a method and a system for intelligently analyzing heterogeneity of endothelial cells in atherosclerosis. The method comprises the following steps: acquiring sample data of the endothelial cells in the atherosclerosis of a patient; performing feature extraction on the sample data of the endothelial cells to obtain gene expression features of the endothelial cells; dividing the endothelial cells into different subgroups according to gene expression characteristics of the endothelial cells and gene expression similarity so as to determine marker genes for distinguishing the different subgroups, and defining and representing characteristics of each subgroup by analyzing expression modes of the marker genes; gene expression differences among different endothelial cell subgroups are compared, differential expression genes of the related endothelial cell subgroups, which are significantly up-regulated or down-regulated in the atherosclerosis process, are identified, and the differential expression genes are used as key molecular markers for understanding functional changes and heterogeneity of endothelial cells. According to the method, the heterogeneity of the endothelial cells in the atherosclerosis can be accurately analyzed.
Owner:SHENZHEN UNIV GENERAL HOSPITAL

Cancer treatment effect prediction method and device, equipment and storage medium

The invention relates to the technical field of machine learning, and discloses a cancer treatment effect prediction method and device, equipment and a storage medium. The method comprises the following steps: carrying out radiomics feature extraction on a CT scanning image to obtain radiomics features; performing interested pathological feature extraction based on an attention mechanism and local pathological feature extraction based on an interested pathological feature extraction result on the pathological image to obtain pathological omics features; performing differential expression gene analysis on the transcriptomics data, and performing differential expression gene screening based on a differential expression gene analysis result to obtain transcriptomics characteristics; and inputting a fusion feature obtained by fusing the radiomics feature, the pathological omics feature, the transcriptomics feature and the clinical data into a cancer treatment effect prediction model to obtain a cancer treatment effect prediction result. According to the embodiment of the invention, the cancer treatment effect is predicted by combining the radiomics characteristics, the pathomics characteristics, the transcriptomics characteristics and the clinical characteristics, and the prediction accuracy can be improved.
Owner:HUNAN UNIV

Treatment of renal cell carcinoma

This disclosure provides methods for treating a subject afflicted with a tumor derived from a renal cell carcinoma. The methods comprise administering a first dose to a subject of an anti-PD-1 antibody or antigen-binding portion thereof and / or an anti-PD-L1 antibody or antigen-binding portion thereof, and administering a second dose to the subject, wherein the subject exhibited differential expression in one or more biomarker genes, e.g., CTLA-4, TIGIT, and / or PD-L2, following administration of the first dose.
Owner:BRISTOL MYERS SQUIBB CO

Endometrial cancer prognosis prediction model based on glycolipid metabolism related genes and construction method of endometrial cancer prognosis prediction model

The invention provides a glycolipid metabolism related gene-based endometrial cancer prognosis prediction model construction method, which comprises the following steps of 1, acquiring data containing gene expression and clinical information, and preprocessing the data; 2, differential expression and prognosis gene screening; 3, constructing a prognosis model; 4, analyzing model gene enrichment; 5, evaluating the immunocompetence of the two GLRG related dangerous groups; and step 6, statistical analysis. According to the technical scheme, more accurate and reliable prognosis evaluation is provided for endometrial cancer by comprehensively analyzing multi-dimensional information such as gene expression, immune characteristics, mutation characteristics and drug sensitivity.
Owner:FUJIAN CANCER HOSPITAL (FUJIAN CANCER INST FUJIAN CANCER PREVENTION & CONTROL CENT)

Colorectal cancer prognosis model construction method based on fatty acid metabolism related genes

PendingCN120319306AHealth-index calculationBiostatisticsOncologyTumor Subtype
The invention discloses a colorectal cancer prognosis model construction method based on fatty acid metabolism related genes, and belongs to the technical field of biomedicine, and the colorectal cancer prognosis model construction method comprises the following steps: S1, obtaining transcriptome data of a colorectal cancer diagnosis individual from a TCGA database; s2, performing difference analysis on fatty acid metabolism related gene expression data of the colorectal cancer tissue and the normal tissue, and screening out differentially expressed genes; s3, performing single-factor Cox regression analysis on the differentially expressed genes, and screening out genes related to colorectal cancer prognosis; according to the construction method of the colorectal cancer prognosis model based on the fatty acid metabolism related genes, provided by the invention, the tumor immunotherapy reactivity is evaluated by introducing TIDE scores, and the prior art is improved, so that the immune escape potential and the immunotherapy effect of tumor subtypes are analyzed. The prognosis of a colorectal cancer patient is effectively predicted, and a new molecular marker is provided for personalized treatment of the colorectal cancer.
Owner:NANCHANG UNIV

Application of biomarker for early screening of colorectal adenoma and colorectal cancer

The invention belongs to the technical field of tumor molecular biology, and particularly relates to application of a biomarker for early screening of colorectal adenoma and colorectal cancer. The biomarker is clustered protein. Serum samples from normal healthy people, proliferative polyp and adenomatous polyp patients are analyzed through weak cation exchange magnetic beads (WCX-MB) and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS), differential polypeptides in significant differential expression peaks are selected, corresponding differential proteins are identified through high-throughput sequencing, and the differential proteins are identified through high-throughput sequencing. Further, a potential biological marker for early cancerization of intestinal polyp is explored. The biomarker provided by the invention has good diagnostic efficiency on adenoma and colorectal cancer, is obviously superior to a traditional tumor marker, and has important significance on early screening and early diagnosis of colorectal tumor.
Owner:THE FIRST AFFILIATED HOSPITAL OF XIAN MEDICAL UNIV

Macrophage related gene KCNA3 and application thereof

The invention is applicable to the technical field of molecular biology, and provides a macrophage related gene KCNA3 and application thereof. The invention discloses a macrophage related gene KCNA3 for the first time, and the gene is identified as a macrophage related differential expression gene of a patient with type 2 diabetes mellitus with carotid atherosclerosis, and shows high expression in the patient with type 2 diabetes mellitus with carotid atherosclerosis. Through analysis of a public database transcriptome chip and high-throughput sequencing data and further verification of CIBERSORTX and WGCNA algorithms, close association between the KCNA3 gene and the macrophages is confirmed. Based on differentiated expression of the KCNA3 gene and correlation of the KCNA3 gene and macrophages, the gene can be used as a potential treatment target for further treating patients with the diabetes mellitus with the carotid atherosclerotic plaque, so that a new mechanism participating in disease progression of the diabetes mellitus with the carotid atherosclerotic plaque is disclosed.
Owner:JILIN UNIVERSITY

Method and device for constructing deconvolution model, terminal and medium

The invention provides a deconvolution model construction method and device, a terminal and a medium, and the method comprises the steps: generating simulated space transcriptome data with a cell type proportion label based on single cell transcriptome data, and obtaining real space transcriptome data obtained through sampling based on a 3D concentric sphere sampling strategy, and based on a comparative learning strategy and a domain adversarial network, training an encoder and an initial prediction model by using target space transcriptome data containing differential expression genes obtained by screening from simulation data and real data, and obtaining a feature extraction model for extracting embedded information and a prediction model for predicting a cell type proportion. According to the method, deep learning is combined, target space transcriptome data is used as encoder input, encoder output is used as prediction model input, the model is trained based on domain adversarial learning and contrast learning strategies, a model with good generalization ability is obtained, and high-precision deconvolution and cell type proportion prediction of 3D space transcriptome data are realized.
Owner:SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI

Application of HOXD1 in diagnosis, prognosis and treatment of liver cancer

The invention discloses application of HOXD1 in diagnosis, prognosis and treatment of liver cancer, and particularly relates to application of a reagent for detecting expression of a biomarker HOXD1 in preparation of a product for diagnosing a liver cancer object. The invention discloses application of a reagent for detecting expression of a biomarker HOXD1 in preparation of a product for prognosis of a liver cancer object. The invention discloses an application of HOXD1 as a target in screening medicines for treating liver cancer. The HOXD1 expression inhibitor is applied to preparation of a medicine for treating liver cancer. Differential expression of the HOXD1 in hepatocellular carcinoma tissues and normal hepatocellular carcinoma tissues is clear through research, high expression of the HOXD1 is closely related to the survival reduction period of clinical hepatocellular carcinoma patients, specific knock-down of the HOXD1 can obviously reduce the proliferation capacity of the hepatocellular carcinoma, and a new diagnosis / prognosis marker and a treatment target are provided for early discovery, early treatment and prognosis of the hepatocellular carcinoma. And a new treatment strategy and direction are provided.
Owner:CHONGQING MEDICAL UNIVERSITY

Application of circ0005704 and related biological elements thereof in diagnosis and treatment of recurrent spontaneous abortion with unknown reasons

The invention belongs to the technical field of biological medicine and molecular biology, and particularly relates to application of circ0005704 and related biological elements thereof in diagnosis and treatment of recurrent spontaneous abortion with unknown reasons. Researches find that differential expression and autophagy level of ULK1 in trophoblast cells of URSA patients are increased. High-throughput transcriptome sequencing is combined with bioinformatics analysis, and it is found that miR-26a-5p is down-regulated in URSA patients, is responsible for up-regulation of ULK1 and promotes autophagy of trophoblast cells, so that occurrence of URSA is increased. Through a high-throughput transcriptional set screening strategy and dual luciferase reporter gene analysis, it is found that circ0005704 enhances the expression of ULK1 through miR-26a-5p. In a word, the research of the invention shows that the circ0005704 / miR-26a-5p / ULK1 signal axis participates in the pathogenesis of URSA by adjusting the migration of the trophoblast cells, and a new target and scientific evidence are provided for the clinical treatment of URSA.
Owner:SHANDONG UNIV OF TRADITIONAL CHINESE MEDICINE

Method for improving synthesis of sakuranetin by using yarrowia lipolytica based on transcriptome analysis and application of method

The invention discloses a method for improving synthesis of sakuranetin from yarrowia lipolytica based on transcriptome analysis and application of the method, and belongs to the technical field of gene engineering. Target genes are analyzed and screened through transcriptome sequencing so as to find a method capable of improving sakuranetin synthesis, and the method specifically comprises the steps that an Illumina HiseqTM platform is used for conducting comprehensive transcriptome analysis on an original strain in the logarithmic phase by applying an RNA-seq technology, then transcriptome data are deeply analyzed through KEGG pathway analysis, and the sakuranetin synthesis can be improved. Therefore, the gene showing significant differential expression in the key path of sakuranetin synthesis is identified. And finally, carrying out free expression and integrated expression on the screened key target gene, and verifying the influence on the sakuranetin yield. Finally, a recombinant yarrowia lipolytica strain which is integrated with the YALI0C01859g gene and has high sakuranetin yield is obtained, and the titer of sakuranetin is increased to 344.0 mg / L.
Owner:MAIYUAN LABORATORY

Method and system for evaluating treatment effect of traditional Chinese medicine based on single cell and space transcriptome data

The invention discloses a method and system for evaluating the treatment effect of traditional Chinese medicine based on single cell and spatial transcriptome data, and the method comprises the following steps: respectively obtaining single cell data and spatial transcriptome data of a tissue sample before and after administration, and carrying out the preprocessing; classifying the cells and identifying cell types; the expressed ligand and receptor genes are paired to obtain ligand-receptor pairs, and the ligand-receptor pairs which are differentially expressed before and after administration are screened out; acquiring space coordinate information of a single cell, and constructing a cell interaction network and a differential gene network according to the cell type, the ligand-receptor pair and the space coordinate information; weighting processing is conducted on the cell interaction network and the differential gene network, and comprehensive indexes for evaluating the effect of the traditional Chinese medicine are obtained.The brand-new method for evaluating the disease treatment effect of the traditional Chinese medicine is provided, the method is scientific and reliable, and the treatment effect of the traditional Chinese medicine on complex diseases can be accurately reflected.
Owner:ZHEJIANG UNIV

Drug recommendation method and system for drug effect prediction and / or personalized medication guidance

The invention provides a drug recommendation method for drug effect prediction and / or personalized medication guidance. The drug recommendation method is based on a multi-dimensional differential expression map reference database. According to the invention, the association between the gene and a drug action mechanism or a disease phenotype is inferred through multi-dimensional information of the gene and functional modules including a GO function, a signal channel, transcriptional regulation, protein-protein interaction and the like; and meanwhile, a model integrated statistical method is benefited, and more accurate drug effect prediction and personalized medication guidance are finally realized compared with similar work. The method has a wide application prospect.
Owner:SHANGHAI GENECHEM

Rapid detection method for traumatic brain injury by fusing gene engineering and quantum dots

ActiveCN121281814AMedical data miningHealth-index calculationBio moleculesBioinformatics databases
The invention discloses a rapid detection method for traumatic brain injury by fusing genetic engineering and quantum dots, and relates to the technical field of traumatic brain injury detection. The method comprises the following steps: acquiring a suspected patient biological sample, extracting biomolecule components, and comparing the biomolecule components with a healthy population biomolecule database to obtain related differential expression molecules. A specifically recognizable recombinant antibody is constructed by genetic engineering, and is connected with a quantum dot through a coupling reaction to prepare a detection probe. The probe and a biological sample are mixed and reacted, and the intensity of a fluorescence signal generated by combination is collected by a fluorescence detection device. A standardized signal value is obtained through signal processing algorithm noise reduction and feature extraction, and a preliminary detection result is determined by combining a bioinformatics database evaluation sample. And finally, according to the differential expression molecule, the standardized signal value and the preliminary result, analyzing a data change trend in a preset time window by using a multivariable statistical model, and generating a diagnosis report. According to the method, various technologies are fused, and a new path is provided for traumatic brain injury detection.
Owner:THE FIRST MEDICAL CENT CHINESE PLA GENERAL HOSPITAL

Screening method and device of protein marker combination and storage medium

PendingCN121393555AMedical data miningEnsemble learningDiseaseRuptured abdominal aortic aneurysm
The invention discloses a screening method of a protein marker combination, which is used for risk prediction of abdominal aortic aneurysm or ruptured abdominal aortic aneurysm, and optimizes the stability of a protein expression profile by constructing an initial protein expression profile; screening differential expression proteins by adopting statistical analysis, and preliminarily locking candidate proteins remarkably associated with a disease endpoint based on survival analysis or a risk regression model; performing cross validation by combining a sparse constraint algorithm and a nonlinear feature selection algorithm, and extracting a robust core marker; the independent contribution degree of each marker is evaluated through the standardized weight, and finally the optimal protein combination for disease prediction or diagnosis is determined. According to the method, six core proteins obtained through multi-algorithm cross screening can be detected in serum, multivariable logistic regression and external verification set performance both show good robustness, and an aorta protein fingerprint feature set which can be popularized and explained is formed.
Owner:SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Rape grain weight regulation gene NGAL3 based on whole genome screening and breeding application thereof

The invention discloses a rape grain weight regulation gene NGAL3 based on whole genome screening and a breeding application thereof, based on the seed size and grain weight phenotypic value of a cabbage type rape germplasm resource, a candidate gene interval is positioned by using GWAS; the method comprises the following steps: selecting large-grain-weight and small-grain-weight extreme phenotypic materials, performing transcriptome sequencing in a critical period of seed development, and screening differential expression genes; and performing cross comparison on the GWAS candidate gene and the differential expression gene to obtain a key gene for jointly regulating and controlling the size and the grain weight of the seed, and performing functional verification on the key gene. The thousand seed weights of the created homozygous three mutant strains L1-sg1-1-4-5 and L2-sg1-4-8-16 are obviously increased by 46% and 29% compared with those of the wild type strains. The invention provides a new target for high-yield rape breeding, and non-transgenic high-grain-weight germplasm can be created through gene editing or beneficial allelic variation of NGAL3 is selected and enriched under the assistance of molecular markers.
Owner:ZHEJIANG UNIV

Application of PRDX2 as biomarker in auxiliary diagnosis and prognosis prediction of acute kidney injury

The invention provides application of PRDX2 as a biomarker in auxiliary diagnosis and prognosis prediction of acute kidney injury. Specifically, the invention relates to application of a reagent for detecting the expression quantity of a biomarker PRDX2 in preparation of products for auxiliary diagnosis and prognosis prediction of acute kidney injury. Differential expression of PRDX2 in acute kidney injury patient samples is found for the first time, so that PRDX2 can be used as a biomarker of acute kidney injury for auxiliary diagnosis or prognosis prediction of acute kidney injury, and a new way is provided for diagnosis and prognosis prediction of acute kidney injury.
Owner:THE SECOND XIANGYA HOSPITAL OF CENT SOUTH UNIV

Single cell pseudo-trajectory identification method based on gene co-expression network

ActiveCN119724357ABiostatisticsInference methodsGene rankingSynexpression
The invention belongs to the technical field of single cell data analysis, and particularly relates to a single cell pseudo-trajectory identification method based on a gene co-expression network. Comprising the following steps: S1, constructing a single cell transcription data matrix of behavior gene names and cell names; s2, preprocessing the single-cell transcription data matrix, constructing a cell expression matrix, and performing characteristic gene screening on the cell expression matrix to obtain a single-cell gene expression matrix; s3, constructing a gene co-expression network; s4, constructing a gene rank differential expression network in combination with the single-cell gene expression matrix and the gene co-expression network; and S5, carrying out integrated clustering on the gene rank differential expression network, fusing by using a similarity network to obtain a final clustering result, determining an initial cluster, distributing pseudo time for cells in each cluster, and deducing a cell pseudo trajectory. According to the method, the differentiation track of the cell can be identified, and compared with an original gene expression matrix, a more stable identification result can be obtained by utilizing a relative expression sequence.
Owner:WUHAN INST OF TECH +1

Methods and compositions for quantifying immune cell nucleic acids

PCT designated stage expiredWO2024264065A1Microbiological testing/measurementDiseaseCancer cell
Provided herein is an RNA analysis method for detecting and quantifying RNA (such as RNA from an immune cell or from a cancer cell) and / or for identifying and quantifying immune cell types from which the RNA originated. In some embodiments, expression levels of genes differentially expressed between healthy subjects and subjects having a disease or disorder are determined based on the RNA. In some embodiments, immune cell types from which the RNA originated are identified and quantified. Provided herein are also methods for determining the likelihood that a subject has the disease or disorder, such as a cancer.
Owner:GUARDANT HEALTH INC